Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Stereotactic Body Radiotherapy
•
Prostate Cancer
What fractionation and dose constraints do you use for prostate SBRT?
Answer from: Radiation Oncologist at Community Practice
UCLA King Protocol8 Gy x5PTV 95% of PTV volume to get 95-110% rx doseRectum V50 (20 Gy) < 50%V80 (32 Gy) < 20%V90 (36 Gy) < 10 %V100 (40Gy) < 5%BladderV50 (20 Gy) < 40%V100 (40 Gy) < 1.1%Femurs V40 (16 Gy) < 5%Small Bowel V50 (20Gy) < 1%
Sign in or Register to read more
380
Related Questions
What is your preferred dose to gross lymph nodes when treating non-metastatic high-risk prostate cancer?
Does long term use of 5 alpha reductase inhibitors change the way you evaluate a PSMA PET?
How would you approach de novo metastatic castrate sensitive prostate cancer with extensive locoregional spread causing rectal compression, retroperitoneal lymphadenopathy, and PSA >3000 but no visceral or bone metastases?
What adjuvant treatment would you offer a patient who underwent cystoprostatectomy for a muscle invasive bladder cancer and discovered to also have prostate cancer?
When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?
How do you follow/manage patients with metastatic prostate cancer with undetectable PSA and castration-sensitive but active disease on PSMA PET?
As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
Are there any contraindications to Pluvicto therapy you personally use, given that there are none directly provided by the manufacturer?
Do you offer RT both to the prostate and synchronous oligometastases in de novo oligometastatic prostate cancer?
What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?